The US Food and Drug Administration (FDA) has granted clearance to 3NT Medical’s Peregrine Drivable ENT Scope, which can offer a high-quality view of the sinus anatomy for ear, nose and throat (ENT) surgical procedures.
The anterior and lateral walls of the maxillary sinus, as well as the frontal sinus’ superior and lateral aspects, are hard to reach using endoscopes. This makes it hard for ENT surgeons to access and visualise deep within the sinuses.
3NT Medical’s Peregrine scope gives ENT surgeons the ability to reach the farthest areas of the sinuses and picturise anatomic landmarks closely, with greater image quality and lower levels of resection, both intra- and post-operatively.
These benefits are accomplished using new mechanics, which aid surgeons in sharply angulating the Peregrine’s 2.3mm tip and proceeding further towards the turn, all during single-hand operation.
Furthermore, the device can be used together with the standard 0° rigid endoscope or as the key endoscope in the operating room.
Peregrine can be connected to a reduced-footprint video console, which reduces requirements for huge and high-priced endoscopy towers typically needed for standard endoscopes.
The new single-use sterile device can also boost safety for patients as well as medical staff by eradicating cross-contamination risk. This could lower costs by reducing the sterilisation needs that are required for standard capital endoscopes.
3NT Medical CEO Ehud Bendory said: “This new scope joins our commercially-available Colibri Micro ENT Scope for otologists and demonstrates that 3NT Medical is executing on its vision of creating a portfolio of endoscopes designed specifically for ENT use.
“We designed Peregrine exclusively for ENT surgeons to enable a better surgical experience for them as they strive to provide better outcomes and an enhanced experience for their patients.”
In a study, the 3NT Medical Peregrine showed the ability to offer a complete view of the frontal and sphenoid sinuses as well as a 97.1% view of the maxillary sinus, versus 45.3%, 53.3% and 39.4%, respectively, with 4mm rigid endoscopes ranging from 0° to 70°.